First-fill medication discontinuations and nonadherence to antihypertensive therapy: An observational study

American Journal of Hypertension

Volumn 25, Issue 2, 2012, Pages 195-203

  Evans, Charity D ^a,c   Eurich, Dean T ^b   Remillard, Alfred J ^a   Shevchuk, Yvonne M ^a   Blackburn, David ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

adherence; antihypertensive therapy; blood pressure; hypertension; observational study

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; WARFARIN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC DISEASE; DRUG FORMULATION; DRUG USE; DRUG WITHDRAWAL; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENESCENCE; TREATMENT REFUSAL;

AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CHRONIC DISEASE; DEPRESSION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; SASKATCHEWAN; WARFARIN;

EID: 84856053836     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.198     Document Type: Article

References (29)

1. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19:1190-1196. (Pubitemid 44633590)
2. Vrijens B, Vincze G, Kristano P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-1117. (Pubitemid 351731741)
3. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 2010; 25:284-290.
4. Shah NR, Hirsch AG, Zacker C, Wood GC, Schoenthaler A, Ogedegbe G, Stewart WF. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens 2009; 22:392-396.
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-497. (Pubitemid 41127293)
6. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol 2005; 21:485-488. (Pubitemid 40823600)
7. Larsen J, Andersen M, Kragstrup J, Gram L. High persistence of statin use in a Danish population: Compliance study 1993-1998. Br J Clin Pharmacol 2002;53:375-378. (Pubitemid 34415587)
8. Wong MC, Jiang JY, Gibbs T, Griffiths SM. Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Am J Hypertens 2009; 22:802-810.
9. Simons L, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience, 2004-2006. Med J Australia 2008;188:224-227.
10. Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Sangiorgi Cellini G, Vaccheri A, De Ponti F, Montanaro N. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol 2005; 61:603-609. (Pubitemid 41414244)
11. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005; 365:82-93. (Pubitemid 40082150)
12. Pedan A, Varasteh L, Schneeweiss S. Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. J Manag Care Pharm 2007; 13:487-496. (Pubitemid 350193369)
13. Downey W, Stang MR, Beck P, Osei W, Nichol J. Health Services Databases in Saskatchewan. In: Strom B, ed. Pharamcoepidemiology. 4th edn, Wiley: Philadelphia, PA, 2005, pp. 295-310.
14. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW. Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy 2005; 25:1035-1043. (Pubitemid 41099437)
15. Blackburn DF, Lamb DA, Eurich DT, Johnson JA, Wilson TW, Dobson RT, Blackburn JL. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents. J Hypertens 2007; 25:1499-1505. (Pubitemid 46918839)
16. Evans CD, Eurich DT, Lamb DA, Taylor JG, Jorgenson DJ, Semchuk WM, Mansell KD, Blackburn DF. Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada. J Manag Care Pharm 2009; 15:476-484.
17. Lamb D, Eurich D, McAlister F, Tsuyuki R, Semchuk W, Wilson T, Blackburn D. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003. Circ Cardiovasc Qual Outcomes 2009;2:228-235.
18. Choudhry NK, Shrank WH, Levin RL, Lee JL, Jan SA, Brookhart MA, Solomon DH. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009; 15:457-464.
19. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288: 455-461. (Pubitemid 34787476)
20. Insull W. The problem of compliance to cholesterol altering therapy. J Intern Med 1997; 241:317-325. (Pubitemid 27223997)
21. Benner JS, Chapman RH, Petrilla AA, Tang SS, Rosenberg N, Schwartz JS. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Am J Health Syst Pharm 2009; 66:1471-1477.
22. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 2006; 44:471-477. (Pubitemid 43755427)
23. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 2002; 159:103-108. (Pubitemid 41070734)
24. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992; 45:197-203.
25. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006; 296:2563-2571. (Pubitemid 44903860)
26. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care 2007; 45:521-528.
27. Burke TA, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24:1193-1200. (Pubitemid 43772328)
28. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120:1598-1605.
29. Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010; 48:418-425.